Clinical trial
Clonidine in Attention Deficit Hyperactivity Disorder (ADHD) in Children
NCT00031395 · University of Cincinnati, Other · Completed
Key facts
| NCT number | NCT00031395 |
|---|---|
| Title | Clonidine in Attention Deficit Hyperactivity Disorder (ADHD) in Children |
| Official title | Clonidine in Attention Deficit Hyperactivity Disorder (ADHD) Treatment (CAT) |
| Lead sponsor | University of Cincinnati, Other |
| Collaborators | National Institute of Neurological Disorders and Stroke (NINDS) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Attention Deficit Disorder With Hyperactivity |
| Intervention type | Drug, Other |
| Interventions | clonidine, methylphenidate, placebo |
| Enrollment | 122 |
| Start date | Sep 1, 1999 |
| Completion | Jun 1, 2007 |
| First posted | Mar 5, 2002 |
| Last update posted | May 21, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: